A POTENTIAL BIOMARKER FOR GLIOBLASTOMA?

Glioblastoma is a aggressive brain tumor known for its fast growth and resistance to typical treatments. Research are constantly underway to identify new management strategies, and recently, a unique biomarker named LCA168 has emerged as a potential focus for GBM treatment. LCA168 is a protein that is overexpressed in GBM cells compared to normal